The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
Naesens
L
L
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
Balzarini
J
J
De Clercq
E
E
D000225:Adenine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000627:therapeutic use*; D012192:Retroviridae Infections / Q000188:drug therapy; D013237:Stereoisomerism
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; C069328:9-(3-fluoro-2-phosphonylmethoxypropyl)adenine; C053001:adefovir; D003596:Cytosine; C050127:9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine; D000225:Adenine; D000077404:Cidofovir